MRK vs WST
By Alex · Tickerpine
Merck & Co., Inc. vs West Pharmaceutical Services, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | WST |
|---|---|---|
| Price | $147.76 | $416.42 |
| Market cap | $364.26B | $29.01B |
| P/E ratio | 149.3 | 46.7 |
| ROE | 5.06% | 21.23% |
| Profit margin | 3.64% | 18.81% |
| Revenue growth | 4.70% | 8.70% |
| Dividend yield | 2.30% | 0.25% |
| Beta | 0.12 | 1.14 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs WST in plain English
- MRK is the bigger company — about 12.6× the market cap of WST.
- WST is cheaper on earnings (P/E 46.7 vs 149.3).
- WST earns a higher return on equity (21% vs 5%).
- WST is growing revenue faster (9% vs 5%).
- MRK has the higher dividend yield (2.30% vs 0.25%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
WST return calculator
See what $1,000 in West Pharmaceutical Services, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.